Gene Therapy for Wiskott-Aldrich Syndrome

NCT01515462 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

8

Enrollment

OTHER

Sponsor class

Conditions

Wiskott-Aldrich Syndrome (WAS)

Interventions

GENETIC: TLT003

Sponsor

Fondazione Telethon

Collaborators

[object Object]